New hope for kidney patients: experimental anemia drug shows promise
NCT ID NCT05745883
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called DISC-0974 in 55 adults with chronic kidney disease (not on dialysis) who also have anemia. The goal was to check the drug's safety and how the body processes it. Participants received either the drug or a placebo by injection. The results will help decide if larger studies are warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DISC-0974
- What this could lead to
- If successful, this could lead to a new treatment option for anemia in people with chronic kidney disease who are not on dialysis.
- What could go wrong
- This is an early Phase 1b study with only 55 participants, so results may not apply to everyone. The drug may cause side effects or not improve anemia significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA OF CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Accel Research
DeLand, Florida, 32720, United States
-
CARE Institute - Boise Kidney
Boise, Idaho, 83706, United States
-
Center for Advanced Kidney Research PLC
Saint Clair Shores, Michigan, 48081, United States
-
Centricity Research
Columbus, Ohio, 43213, United States
-
Clinical Advancement Center, PLLC
San Antonio, Texas, 78212, United States
-
Endeavor Clinical Trials
San Antonio, Texas, 78240, United States
-
Flourish Research
Winter Park, Florida, 32789, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Nephrology and Hypertension Specialists, PC-Dalton
Dalton, Georgia, 30720, United States
-
Total Research Group
Miami, Florida, 33126, United States
-
UCLA Clinical and Translational Research
Los Angeles, California, 90095, United States
-
US Renal Care Inc.
Lone Tree, Colorado, 80124, United States
-
Washington Nephrology Associates, LLP
Alexandria, Virginia, 22304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a pill tailored to inflammation boost red blood cells in kidney disease?